Izindaba zakamuva ngomdlavuza
I-CAR T Cell therapy ye-AIDS ehlobene ne-B-Cell malignancies
I-CAR T cell therapy ye-B cell malignancies ehlobene ne-HIV ihilela ukuguqulwa kofuzo ama-T cell esiguli ukuze aveze ama-chimeric antigen receptors (CARs)...
Izibalo zomdlavuza eNdiya 2024: Izehlakalo, izilinganiso kanye nokuqagela
Ngo-2024, umdlavuza uzohlala uyinselelo enkulu yezempilo eNdiya. Izwe libona amacala amasha angaphezu kwezigidi eziyi-1.5 ngonyaka. Umdlavuza wamabele nowomlomo iningi...
I-India imemezele inhloko-dolobha yomdlavuza emhlabeni - umbiko we-Apollo
I-India imemezele inhloko-dolobha yomdlavuza emhlabeni I-India yaqokwa “njengenhloko-dolobha yomdlavuza emhlabeni” kuhlelo lwesine lwe-Apollo Hospitals'...
I-Mirvetuximab soravtansine-gynx igunyazwe yi-USFDA nge-FRα positive, i-platinum-resistant epithelial ovarian, fallopian tube, noma umdlavuza we-peritoneal oyinhloko.
Mashi 2024: Ukuphathwa Kwezokudla Nezidakamizwa kunikeze imvume yokuthi i-mirvetuximab soravtansine-gynx (Elahere, ImmunoGen, Inc. [manje eseyingxenye ye-AbbVie]) ukuthi...
I-Ponatinib ene-chemotherapy ithole ukugunyazwa okusheshayo yi-USFDA ye-Philadelphia chromosome-positive acute lymphoblastic leukemia esanda kutholakala.
Mashi 2024: I-Ponatinib (Iclusig, Takeda Pharmaceuticals USA, Inc.) ithole ukugunyazwa okusheshayo kwa-Food and Drug Administration ukuze isetshenziswe ngokuhlanganisa...
I-Zanubrutinib igunyazwe yi-USFDA ngokubuyela emuva noma i-refractory follicular lymphoma
Mashi 2024: I-Zanubrutinib (i-Brukinsa, i-BeiGene USA, Inc.) ihlanganiswe ne-obinutuzumab inikezwe imvume esheshayo yi-Food and Drug...
I-Nivolumab ihlanganiswe ne-cisplatin ne-gemcitabine igunyazwe yi-USFDA nge-carcinoma ye-urothelial engasahlekiyo noma ye-metastatic.
Mashi 2024: I-Food and Drug Administration inikeze imvume yokusetshenziswa kwe-nivolumab (Opdivo, Bristol-Myers Squibb Company) ngokuhlanganyela ne-cisplatin...
I-Inotuzumab ozogamicin igunyazwe yi-USFDA yeziguli zezingane ezine-acute lymphoblastic leukemia
6 Mashi 2024: I-Inotuzumab ozogamicin (Besponsa, Pfizer) inikezwe imvume yi-Food and Drug Administration yokwelapha ukuphindela emuva noma...
Ukuqonda ubudlelwano phakathi kwe-MRD kanye ne-CAR T-Cell therapy
Iyini i-MRD ekwelapheni umdlavuza? I-Measurable Residual Disease, noma i-MRD, igama lamangqamuzana omdlavuza ambalwa kakhulu ahlala emzimbeni ngemva noma phakathi...
I-Mesenchymal stem cell therapy ezinkingeni ze-neurological
Izifo zemizwa ziyizinkinga ezinkulu emhlabeni wonke ngoba zibangela ukufa nokukhubazeka okuningi. Ukwelashwa kwesintu akusebenzi ngaso sonke isikhathi,...
Ukuqokwa kwesidakamizwa sezintandane kunikezwe yi-FDA ku-CART T-Cell Therapy A2B530 yokwelapha umdlavuza we-colorectal.
NgoMashi 2024, ukukhishwa kwezindaba kwathi i-A2B530 (A2 Biotherapeutics), i-CAR T-cell therapy, yayinikezwe i-Orphan Drug Designation yokwelapha umdlavuza we-colorectal ...
I-Amtagvi ka-Iovance igunyazwe yi-USFDA njengokwelashwa kwe-T-cell yokuqala yesimila esiqinile
I-Iovance Biotherapeutics' yokuqala yohlobo lwayo yokwelashwa kwamasosha omzimba yavunywa yi-FDA. Lokhu kusho ukuthi ukwelashwa kwe-T-cell, okushintshe indlela ezinye izinhlobo ze-...
Dinga usizo? Ithimba lethu likulungele ukukusiza.
Sifisela ukululama okusheshayo kothandekayo wakho futhi oseduze.